STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 95 filers reported holding STOKE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.14 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,049 | -65.8% | 12,449 | -7.9% | 0.00% | – |
| Q2 2023 | $143,622 | +57.8% | 13,511 | +37.0% | 0.00% | – |
| Q4 2022 | $90,998 | -27.8% | 9,859 | +0.2% | 0.00% | – |
| Q3 2022 | $126,000 | -2.3% | 9,839 | +1.1% | 0.00% | – |
| Q2 2022 | $129,000 | -45.8% | 9,730 | +58.2% | 0.00% | – |
| Q1 2021 | $238,000 | -70.8% | 6,151 | -53.3% | 0.00% | – |
| Q4 2020 | $815,000 | +235.4% | 13,165 | +80.8% | 0.00% | – |
| Q3 2020 | $243,000 | – | 7,281 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 296,822 | $7,551,000 | 1.86% |
| RTW INVESTMENTS, LP | 3,644,248 | $92,710,000 | 1.40% |
| Cormorant Asset Management, LP | 1,278,276 | $32,519,000 | 1.32% |
| Redmile Group, LLC | 2,381,958 | $60,597,000 | 1.06% |
| HighVista Strategies LLC | 47,594 | $1,211,000 | 0.80% |
| Birchview Capital, LP | 15,000 | $382,000 | 0.26% |
| GILDER GAGNON HOWE & CO LLC | 1,123,355 | $28,578,000 | 0.15% |
| Artal Group S.A. | 250,000 | $6,360,000 | 0.14% |
| Tekla Capital Management LLC | 99,263 | $2,525,000 | 0.08% |
| Casdin Capital, LLC | 120,000 | $3,053,000 | 0.08% |